Search - tctmd.com

Displaying 841 - 860 of 1012

Sort: Relevancy | Date

Presentation

Three-Year Outcomes after TAVR with the CoreValve Prosthesis

Presenter: Michael Gotzmann

June 30, 2014

Presentation TVT 2014

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Michael J. Mack

June 07, 2014

Presentation TVT 2014

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Presenter: Michael J. Reardon

June 07, 2014

Presentation TVT 2014

Magnitude of the Problem: Frequency and Presentation of Bioprosthetic Surgical Valve Failure

Presenter: Michael J. Mack

June 07, 2014

Presentation TVT 2014

A Surgeons Perspective on TMVR: What are the Caveats?

Presenter: Michael J. Mack

June 06, 2014

Presentation TVT 2014

Lotus - Status of the US Clinical Trial and Case Examples

Presenter: Ted E. Feldman, Michael J. Reardon

June 06, 2014

Presentation TVT 2014

The High-Risk Randomized Trial

Presenter: Michael J. Reardon

June 05, 2014

Presentation

Prognostic Value of ‘Routine’ Cardiac Stress Imaging 5 Years After PCI

Presenter: Michael J. Zellweger

May 14, 2014

Presentation ECHO 2014

Systolic Heart Failure: Review of Cardiomyopathies

Presenter: Michael H. Picard

April 10, 2014

Presentation

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presenter: A. Michael Lincoff

April 04, 2014

Presentation Physiology and Intravascular Imaging 2014

Evaluation of Left Main Stenosis ALWAYS Requires Hemodynamic Assessment

Presenter: Michael J. Lim

March 28, 2014

Presentation

Effect of Collateral Flow on Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke

Presenter: Michael P. Marks

March 10, 2014

Presentation CTO 2014

The Current CTO Toolbox and Regional Availability

Presenter: R. Michael Wyman

February 27, 2014

Presentation

Evaluation of Aortic Regurgitation Immediately Post-TAVR

Presenter: Michael H. Picard

February 05, 2014

Presentation ISET 2014

SMART™ Stent in the Treatment of Obstructive Superficial Femoral Artery Disease: Three-year Clinical Outcomes from the STROLL TRIAL

Presenter: Michael R. Jaff

January 20, 2014

Presentation

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Presenter: Michael R. Jaff

January 20, 2014

Presentation

Why is there So Much Excitement Over Renal Denervation?

Presenter: Michael R. Jaff

December 01, 2013

Presentation

Comprehensive Management of Carotid Artery Disease: Standard and Novel Approaches

Presenter: Michael R. Jaff

December 01, 2013

Presentation TCT 2013

Potential for Rivaroxaban Use in ACS and in the PCI Patient: Why Different Interpretations of the Same Data in the US and Europe?

Presenter: C. Michael Gibson

October 31, 2013

Presentation TCT 2013

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Presenter: Michael Ezekowitz

October 31, 2013

Advertisement

Three-Year Outcomes after TAVR with the CoreValve Prosthesis

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Direct Aortic TAVR: Indications, Optimal Technique, and Outcomes

Magnitude of the Problem: Frequency and Presentation of Bioprosthetic Surgical Valve Failure

A Surgeons Perspective on TMVR: What are the Caveats?

Lotus - Status of the US Clinical Trial and Case Examples

The High-Risk Randomized Trial

Prognostic Value of ‘Routine’ Cardiac Stress Imaging 5 Years After PCI

Systolic Heart Failure: Review of Cardiomyopathies

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Evaluation of Left Main Stenosis ALWAYS Requires Hemodynamic Assessment

Effect of Collateral Flow on Patients Undergoing Endovascular Therapy for Acute Ischemic Stroke

The Current CTO Toolbox and Regional Availability

Evaluation of Aortic Regurgitation Immediately Post-TAVR

SMART™ Stent in the Treatment of Obstructive Superficial Femoral Artery Disease: Three-year Clinical Outcomes from the STROLL TRIAL

SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease

Why is there So Much Excitement Over Renal Denervation?

Comprehensive Management of Carotid Artery Disease: Standard and Novel Approaches

Potential for Rivaroxaban Use in ACS and in the PCI Patient: Why Different Interpretations of the Same Data in the US and Europe?

Management of a Patient on Novel Oral Anticoagulants Needing Urgent Cath

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content